INTRODUCTION
Cryptococcus neoformans is a ubiquitous saprophytic fungus that may become pathogenic, particularly in immunosuppressed patients 1 . Among patients with human immunodeficiency virus (HIV), cryptococcal meningoencephalitis is associated with mild meningeal inflammation and a high fungal burden 2,3 . Central nervous system (CNS) involvement can be either meningeal or parenchymal. As the infection spreads along the Virchow-Robin spaces, these structures may become dilated with mucoid and gelatinous materials produced by the capsule of the organism. This marked dilatation and filling of the Virchow-Robin spaces is referred to as a gelatinous pseudocyst 4 .
CASE REPORT
A 24-year-old man was admitted to the Natan Portella Institute of Tropical Diseases (Teresina, State of Piauí, Brazil) with a headache, vomiting, drowsiness and mental confusion progressing for two weeks that was associated with seizures. He was infected with HIV-1 but had stopped antiretroviral therapy six months prior. Upon arrival, he was obnubilated with normal fundoscopy, generalized myotatic hyperreflexia and abnormal plantar responses. There were no signs of meningeal irritation.
Brain magnetic resonance imaging (MRI) showed multiple and bilateral hypointense T1 and hyperintense T2 cyst-like lesions located on the periventricular white matter, basal ganglia, mammillary bodies, midbrain peduncles and dentatus nucleus without mass effects and mild post-gadolinium enhancement only in the right caudate head ( Figure 1 ). No meningeal enhancement was noted. Findings of a lumbar puncture procedure showed an opening pressure of 17cm H2O. The cerebral spinal fluid (CSF) was clear, the white blood cell count was 1cell/mm3, the CSF glucose was 48mg/dL, and the total protein was 53mg/dL. India ink staining revealed typical round encapsulated yeast organisms consistent with Cryptococcus neoformans. The cluster of differentiation antigen 4 (CD4)+ T-cell count was 6 cells/µL, and the human immunodeficiency virus (HIV)-1 viral load was 138,000 units/mm3. A chest X-ray was normal. The patient was started on IV amphotericin B deoxycholate therapy in the intensive care unit. A few days later, his mental status worsened, he developed respiratory failure associated with hemodynamic instability, and he died 18 days after admission.
DISCUSSION
Cryptococcosis is the most frequent opportunistic fungal infection that involves the CNS in patients with acquired immunodeficiency syndrome (AIDS) or in other immunocompromised patients 5,6 . The absence of clinical signs of meningeal irritation and CSF pleocytosis reflects the paucity of inflammation due to the severe condition of immunosuppression in these patients 1,3 .
The radiology of this disease demonstrates the ease by which the fungi multiply and disseminate within the host under an incipient immunologic response 7,8 . Central nervous system involvement is secondary to a hematogenous spread and usually results from the reactivation of a prior silent pulmonary infection 1 . Meningitis is often the primary manifestation and is most pronounced at the base of the brain. Parenchymal involvement is seen as cryptococcomas, dilated Virchow-Robin spaces or enhanced cortical nodules 9 . The meningeal infection along the base of the skull may extend along the Virchow-Robin spaces, which may dilate with mucoid gelatinous material produced by the capsule of the organism. Because membranes are not formed between these spaces and the adjacent brain parenchyma, these cysts have been called gelatinous pseudocysts 2,3 .
The gelatinous pseudocysts tend to exhibit a soap bubble appearance by MRI, as observed in the present case ( Figure 1 ). These pseudocysts appear as multiple, small, round or oval cysts in the basal ganglia, thalami, midbrain, cerebellum and the periventricular regions with a low to intermediate T1WI signal (from mucin), a high T2WI signal and a low T2-FLAIR signal 4,7–9 . Significant contrast enhancements of the pseudocysts, cryptococcomas or meninges are rarely noted in immunocompromised patients due to their underlying immunosuppression and the non-immunogenic nature of the polysaccharide capsule 2,4 . Immunocompetent patients tend to present with localized neurological disease, more intense inflammatory responses and improved clinical outcomes 4,10 . The demonstration of pseudocyst clusters in the basal ganglia and thalami in immunocompromised patients strongly suggests a cryptococcal infection 4,7–9 . These lesions reflect the pathological mechanism of CNS invasion by the fungus.